Pharvaris NV (PHVS)
22.29
+1.25
(+5.94%)
USD |
NASDAQ |
Nov 22, 16:00
22.08
-0.20
(-0.92%)
After-Hours: 20:00
Pharvaris EPS Diluted (Quarterly): -0.8469 for Sept. 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.8469 |
| June 30, 2024 | -0.5927 |
| March 31, 2024 | -0.5655 |
| December 31, 2023 | -0.8185 |
| September 30, 2023 | -0.6315 |
| June 30, 2023 | -0.5849 |
| March 31, 2023 | -0.7185 |
| December 31, 2022 | -1.186 |
| September 30, 2022 | -0.2518 |
| June 30, 2022 | -0.4048 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.5386 |
| December 31, 2021 | -0.4232 |
| September 30, 2021 | -0.3301 |
| June 30, 2021 | -0.5544 |
| March 31, 2021 | -0.7953 |
| December 31, 2020 | -0.4127 |
| September 30, 2020 | -0.2351 |
| June 30, 2020 | -0.1987 |
| March 31, 2020 | -0.1136 |
| December 31, 2019 | -0.1203 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-1.186
Minimum
Dec 2022
-0.1136
Maximum
Mar 2020
-0.5162
Average
-0.5465
Median
EPS Diluted (Quarterly) Benchmarks
| uniQure NV | -0.91 |
| ProQR Therapeutics NV | -0.11 |
| Merus NV | -1.46 |
| argenx SE | 1.39 |
| Pharming Group | -0.02 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.87M |
| Total Expenses (Quarterly) | 41.69M |
| Enterprise Value | 867.99M |
| Earnings Yield | -12.67% |